IPCS INCHEM Home

    WORLD HEALTH ORGANIZATION             FOOD AND AGRICULTURE
                                          ORGANIZATION
    ORGANISATION MONDIALE DE LA SANTE     ORGANISATION POUR L'ALIMENTATION
                                          ET L'AGRICULTURE

                                                      VBC/DS/80.44

                                                      ORIGINAL: ENGLISH






    DATA SHEETS ON PESTICIDES No. 44

    March 1980

    FENSULFOTHION






         It must be noted that the issue of a Data Sheet for a
    particular pesticide does not imply endorsement of the pesticide by
    WHO or FAO for any particular use, or exclude its use for other
    purposes not stated. While the information provided is believed to
    be accurate according to data available at the time when the sheet
    was compiled, neither WHO nor FAO are responsible for any errors or
    omissions, or any consequences therefrom.

    The issue of this document does    Ce document ne constitue pas une
    not constitute formal              publication. Il ne doit faire
    publication. It should not be      l'objet d'aucun compte rendu ou
    reviewed, abstracted or quoted     résumé ni d'aucune citation sans
    without the agreement of the       l'autorisation de l'Organisation
    Food and Agriculture               des Nations Unies pour
    Organization of the United         l'Alimentation et l'Agriculture
    Nations or of the World Health     ou de l'Organisation Mondiale de
    Organization.                      la Santé.

                             CLASSIFICATION:

                             Primary use: Insecticide and nematicide

                             Secondary use: None

                             Chemical group: Organophosphorus compound

                             Date issued:  March 1980

    1.  GENERAL INFORMATION

    1.1  COMMON NAME:

    fensulfothion (ISO)

    1.1.1  Identity:

    O,O-diethyl O-4-(methylsulfinyl)phenyl phosphorothioate

    CHEMICAL STRUCTURE

    1.1.2  Synonyms:

    Terracurp(R)
    Dasanit(R)

    Local synonyms:

    1.2  SYNOPSIS:

    An organophosphorus insecticide and nematicide of high mammalian
    toxicity: it may be absorbed through the skin, by inhalation and
    from the gastrointestinal tract. It is active upon metabolism.

    1.3  SELECTED PROPERTIES

    1.3.1  Physical characteristics

    An oily liquid of a yellowish colour, b.p. 138 to 141°C at 1.3 Pa.

    1.3.2  Solubility

    Slightly soluble in water (1.54 g/l at 25°C) and soluble in most
    organic solvents.

    1.3.3  Stability

    Stable under normal conditions of storage and use. Half life of 120
    hours at 81°C and ph 2.5-6.0.

    1.3.4  Vapour pressure (volatility)

    low: < 10-6 mbar at 20°C.

    1.4  AGRICULTURE, HORTICULTURE AND FORESTRY

    1.4.1  Common formulations

    Spray concentrate, 6 lbs a.i./gal (600 g/l); granules 50, 100, and
    150 g/kg.

    1.4.2  Susceptible pests

    Nematodes and soil insects.

    1.4.3  Use pattern

    Fensulfothion is a systemic organophosphorus nematicide and
    insecticide, which is used against soil nematodes (free living, root
    knot and cyst forming nematodes) and a broad spectrum of soil borne
    insects in field crops, vegetables and fruit. It is also used
    against nematodes in turf grasses, flowers and ornamental plants.
    For most cultures the material is applied before planting or sowing
    or at planting; for others, fensulfothion is applied in the soil in
    established cultures.

    1.4.4  Unintended effects

    None observed.

    1.5  PUBLIC HEALTH PROGRAMME

    Not used in public health programmes.

    1.6  HOUSEHOLD USE

    None, due to toxicity.

    2.  TOXICOLOGY AND RISKS

    2.1  TOXICOLOGY - MAMMALS

    2.1.1  Absorption route

    Rapidly absorbed by the gastrointestinal tract and by inhalation.
    Dermal absorption is somewhat slower although dermal toxicity is
    relatively high.

    2.1.2  Mode of action

    Cholinesterase inhibition after conversion to the oxygen analogue
    fensulfoxon.

    2.1.3  Excretion products

    In mammals, fensulfothion is metabolized largely through oxidative
    and hydrolyric pathways. It is excreted, primarily in the urine, as
    ethyl and diethyl esters of thiophosphoric acid, p-methyl
    sulphinylphenol and p-methylsulfonylphenol.

    2.1.4  Toxicity; single dose

    Oral:  LD50 Rat (M): 3.96-10.5 mg/kg
           LD50 Rat (F): 1.8-2.3 mg/kg

    Dermal:  LD50 Rat (M): 14-30 mg/kg
             LD50 Rat (F): 3.5-13 mg/kg

    Inhalation: LC50 (M) rats 113 mg/m3 of air, 1 hour exposure
                LC50 (M) rats 29.5 mg/m3 of air, 4 hour exposure

    2.1.5  Toxicity, repeated doses

    The highest daily intraperitoneal dose of fensulfothion that can be
    tolerated by rats for a period of 60 days without occurrence of
    mortality is 0.25 mg/kg bw.

    Oral: See dietary studies below (2.1.6).

    Cumulation of compound: Fensulfothion is not cumulative in body
    tissues.

    Cumulation of effects: Repeated exposure to sub-lethal amounts may
    reduce cholinesterase activity to hazard levels.

    2.1.6  Dietary studies.

    Short-term: Groups of female rats were fed fensulfothion for eight
    weeks at dosage level of 0, 0.5, 1 and 2 mg/kg diet. Erythrocyte
    cholinesterase inhibition was observed at 2 mg/kg while plasma and
    brain levels were unaffected. No cholinesterase inhibition was
    observed at lower dose levels. Mortality, growth, haematology and
    clinical chemistry parameters were normal.

    Groups of dogs were fed fensulfothion in the diet at levels of 0, 1,
    2, 5 and 10 mg/kg diet for 12 weeks. Inhibition of cholinesterase
    was observed in serum and erythrocyte at 2 mg/kg and above. At 5 and
    10 mg/kg cholinergic effects and weight loss were observed.

    Long-term: Groups of rats were fed fensulfothion in the diet for
    17 months at dietary levels of 0, 1, 5 and 20 mg/kg diet. Mortality
    of males was increased at 5 and 20 mg/kg. Growth of males and
    females was slightly impaired at 20 mg/kg. Cholinesterase inhibition
    was found in serum (19%), erythrocytes (21%), and brain (24%) in
    females fed 1 mg/kg and above in males at 5 mg/kg and above. No
    effects were observed on gross or histological examination of organs
    and tissues.

    Groups of dogs (2 males and 2 females/group) were fed fensulfothion
    in the diet at levels of 0, 1, 2 and 5 mg/kg diet for two years.
    Severe weight loss and reduced food consumption accompanied by
    cholinergic signs were evident in the early weeks of the study at
    5 mg/kg. After the second month, food consumption increased and lost
    body weight was regained. Slight cholinergic signs were also
    observed at 2 mg/kg at the beginning of the study. Reduction of
    serum and erythrocyte cholinesterase was evident at 5 mg/kg
    throughout the study. Slight reduction was observed at 2 mg/kg with
    no effects noted at 1 mg/kg. No death occurred during the feeding
    and haematology and gross and histopathologic examination of tissues
    and organs were normal.

    2.1.7  Supplementary studies of toxicity

    Carcinogenicity: No information.

    Reproduction studies and teratogenicity: A three generation
    reproduction study conducted on mice, showed that levels of
    fensulfothion fed at 20 and 5 mg/kg diet, although toxic to mice,
    did not affect reproduction. Tests on pregnant New Zealand albino
    rabbits showed that fensulfothion at dosage levels of 0.05 and
    0.1 (mg/kg)/day, did not affect pregnancy or foetal mortality; there
    was no evidence of abnormal foetal development at 0.5 (mg/kg)/day.

    Mutagenicity: A dominant lethal study conducted on mice did not
    indicate any mutation effect.

    Delayed neurotoxicity: Fensulfothion caused no delayed neurotoxic
    effects in hens in either acute toxicity tests or in subchronic
    feeding experiments using high dose levels.

    2.1.8  Modification of toxicity

    No potentiation was observed when fensulfothion was administered in
    combination with 17 other anticholinesterase pesticides.

    2.2  TOXICOLOGY - MAN

    2.2.1   Absorption

    See 2.1.1

    2.2.2  Dangerous doses

    Single: Not known.

    Repeated: Not known.

    2.2.3  Observations of occupationally exposed workers

    Studies were performed to evaluate the toxicity of a 30 g/kg
    granular formulation of fensulfothion for potential hazards to
    persons using it in rice fields, and to those working in treated
    plantations. No significant inhibition of cholinesterase activity
    was noted either in persons who worked in a crop treated with with
    the granules at 40 kg/ha or in those who applied fensulfothion
    granules by hand.

    2.2.4  Observations on exposure of the general population

    No information.

    2.2.5  Observations of volunteers

    A 50 g/kg granular formulation of fenitrothion was applied,
    air-tight, for two periods of two hours daily to the forearm of
    three persons on five consecutive days. During the exposure periods,
    no person suffered any ill effect or inhibition of cholinesterase
    activity.

    2.2.6  Reported mishaps

    No information.

    2.3  TOXICITY TO NON MAMMALIAN SPECIES

    2.3.1  Fish

    Bluegill           TLm 0.12 mg/l (96 hours)
    Rainbow trout      TLm 8.6 mg/l (96 hours)
    Carp               TLm 5.7 mg/l (48 hours)

    2.3.2  Birds

    Mallards               LD50 0.749 mg/kg
    Starling               LD50 0.56 mg/kg
    House sparrow          LD50 0.32 mg/kg
    Redwinged blackbird    LD50 0.32 mg/kg
    Coupon grackle         LD50 0.42 mg/kg

    2.3.3  Other species

    No information.

    3.  FOR REGULATORY AUTHORITIES - RECOMMENDATIONS ON REGULATION OF
        COMPOUND

    3.1  RECOMMENDED RESTRICTIONS ON AVAILABILITY

    (for definition of categories, see introduction)

    Liquid formulations above 15% category 21 all others category 3
    Solid formulations 10% or above category 31 all others category 4

    3.2  TRANSPORTATION AND STORAGE

    All formulations - Should be transported or stored in clearly
    labelled rigid and leakproof containers, under lock and key, secure
    from access by unauthorized persons and children. No food or drink
    should be transported or stored in the same compartment.

    3.3  HANDLING

    Formulations in categories 3 and 4 - Protective clothing should be
    used by those handling the compound. Adequate facilities should be
    available at all times during handling and should be close to the
    site of handling. Eating, drinking and smoking should be prohibited
    during handling and before washing after handling.

    Formulations in category 5 - No facilities other than those needed
    for handling of any chemical may be required.

    3.4  DISPOSAL AND/OR DECONTAMINATION OF CONTAINER:

    Containers may be decontaminated (see para. 4.3). Decontaminated
    containers should not be used for food and drink. If not
    decontaminated, containers should be burned or crushed and buried
    below topsoil. Care must be taken to avoid subsequent contamination
    of water sources.

    3.5  SELECTION, TRAINING AND MEDICAL SUPERVISION OF WORKERS

    All formulations - Pre-employment medical examination of workers
    desirable. Workers suffering from active hepatic or renal disease
    should be excluded from contact. Pre-employment and periodic
    cholinesterase tests for workers essential for those handling
    concentrates and desirable for applicators. Special account should
    be taken of the workers' mental ability to comprehend and follow
    instructions. Training of workers in techniques to avoid contact
    essential.

    3.6  ADDITIONAL REGUlATIONS RECOMMENDED IF DISTRIBUTED BY AIRCRAFT

    All formulations - Pilots and loaders should have special training
    in application methods and recognition of early symptoms of
    poisoning, and must wear a suitable respirator. Flagmen, if used,
    should wear overalls and be located well away from the dropping
    zone.

    3.7  LABELLING

    All formulations - Minimum cautionary statement: "Fensulfothion is
    an organophosphorus compound which inhibits cholinesterase. It is
    poisonous if swallowed. It may be absorbed through the skin or
    inhaled as dusts or mists. Avoid skin contact; wear protective
    gloves, clean protective clothing and a respirator when handling the
    material. Wash thoroughly with soap and water after using. Keep the
    material out of reach of children, and well away from foodstuffs,
    animal feed and their containers. If poisoning occurs, call a
    physician. Atropine and pralidoxime are specific antidotes and
    artificial respiration may be needed".

    3.8  RESIDUES IN FOOD:

    Maximum residue limits have been recommended for fensulfothion by
    the Joint FAO/WHO Meeting on Pesticide Residues. These are subject
    to change when reviewed.

    4.  PREVENTION OF POISONING IN MAN AND EMERGENCY AID

    4.1  PRECAUTIONS IN USE

    4.1.1  General

    Fensulfothion is an organophosphorus pesticide of high toxicity. It
    penetrates the intact skin and is also absorbed by inhalation of
    dust and spray mists and from the gastrointestinal tract.
    Concentrated formulations should be handled by trained personnel
    wearing protective clothing.

    4.1.2  Manufacture and formulation

    T.L.V.: no information. Formulation should not be attempted without
    advice from the manufacturer. Closed system and forced ventilation
    may be required to reduce as much as possible the exposure of
    workers to the chemical. Protective equipment for the skin and
    respiratory protection is usually necessary.

    4.1.3  Mixers and applicators

    When opening the container and when mixing, protective impermeable
    boots, clean overalls, gloves and respirator should be worn. Mixing,
    if not mechanical, should always be carried out with a paddle of
    appropriate length. When spraying or during aerial applications, a
    face mask should be worn, as well as an impermeable hat, boots and
    gloves. The applicator should avoid working in spray mist and avoid
    contact with the mouth. Particular care is needed when equipment is
    being washed after use. All protective clothing should be washed
    immediately after use, including the insides of gloves. Splashes
    must be washed immediately from the skin or eyes with large
    quantities of water. Before eating, drinking or smoking, hands and
    other exposed skin should be washed.

    4.1.4  Other associated workers (including flagmen in aerial
           operations)

    Persons exposed to fensulfothion and associated with its application
    should wear protective clothing and observe the precautions
    described above in 4.1.3 under "mixers and applicators".

    4.1.5  Other populations likely to be affected

    With good agricultural and manufacturing practice subject to 4.2
    below, other populations should not be exposed to hazardous amounts
    of fensulfothion.

    4.2  ENTRY OF PERSONS INTO TREATED AREAS:

    Unprotected persons should be kept out of treated areas for at least
    one day.

    4.3  DECONTAMINATION OF SPILLAGE AND CONTAINERS:

    Residues in containers should be emptied in a diluted form into a
    deep pit taking care to avoid contamination of ground waters. The
    empty containers may be decontaminated by rinsing two or three times
    with water and scrubbing the sides. An additional rinse should be
    carried out with 5% sodium hydroxide solution which should remain in
    the container overnight. Impermeable gauntlets should be worn during
    the work and a soakage pit should be provided for the rinsings.
    Decontaminated containers should not be used for food and drink.
    Spillage of fensulfothion and its formulations should be removed by
    washing with 5% sodium hydroxide solution and then rinsing with
    large quantities of water.

    4.4  EMERGENCY AID

    4.4.1  Early symptoms of poisoning

    These may include excessive sweating, headache, weakness, giddiness,
    nausea, vomiting, stomach pains, blurred vision, slurred speech and
    muscle twitching. Later there may be convulsions and coma.

    4.4.2  Treatment before person is seen by a physician if these
           symptoms appear following exposure

    The person should stop work immediately, remove clothing and wash
    the affected skin with soap and water if available, and flush the
    area with large quantities of water. If swallowed, vomiting should
    be induced, if the person is conscious. In the event of collapse,
    artifical respiration should be given, bearing in mind that if
    mouth-to-mouth resuscitation is used, vomit may contain toxic
    amounts of fensulfothion.

    5.  FOR MEDICAL AND LABORATORY PERSONNEL

    5.1  MEDICAL DIAGNOSIS AND TREATMENT IN CASES OF POISONING

    5.1.1  General information

    Fensulfothion is an organophosphorus pesticide of high toxicity,
    which is easily absorbed through the intact skin as well as by
    inhalation and from the gastrointestinal tract. It acts by
    inhibiting acetylcholinesterase. Continued exposure to low amounts
    may reduce blood cholinesterase activity to hazard levels.

    5.1.2  Symptoms and signs

    Initial symptoms of poisoning may include excessive sweating,
    headache, weakness, giddiness, nausea, vomiting, stomach pains,
    blurred vision, slurred speech and muscle twitching. More advance
    symptoms of poisoning may be convulsions, coma, loss of reflexes and
    loss of sphincter control.

    5.1.3  Laboratory

    The most important laboratory finding is reduction in activity of
    blood cholinesterases. Urinary levels of organic phosphorus
    containing metabolites may also be able to be used as a measure for
    exposure. Neither method is specific for fensulfothion.

    5.1.4  Treatment

    If the pesticide has been ingested, unless the patient is vomiting,
    rapid gastric lavage should be performed using 5% sodium
    bicarbonate, if available. For skin contact, the skin should be
    washed with soap and water. If the compound has entered the eyes,
    they should be washed with large quantities of isotonic saline or
    water. An adult with manifest peripheral symptoms should be treated
    with 2-4 atropine sulfate, if necessary repeated every 15 minutes up
    to 100 mg within 24 hours, and with 1-2 g of pralidoxime chloride or
    250 mg of toxogonin by slow intravenous injection. Diazepam may be
    given for the control of convulsions. The patient's condition
    including respiration, blood pressure, pulse frequency, salivation
    and convulsions, should be carefully observed as a guide to further
    administration of atropine. If the patient is cyanotic, artificial
    respiration should be given at the same time as atropine sulfate,
    The airways should be kept free and artificial respiration should be
    applied, if required, preferably by mechanical means. If necessary
    intubation should be performed. Contraindications are morphine,
    barbiturates, other tranquillizers and central stimulants of all
    kinds.

    5.1.5  Prognosis

    If the acute toxic effect is survived and adequate artificial
    respiration has been given, if needed, the chances of complete
    recovery are good. However, in very severe cases, particularly if
    artificial respiration has been inadequate, prolonged anoxia may
    give rise to permanent brain damage.

    5.1.6  Reference of previous reported cases

    None.

    5.2  SURVEILLANCE TESTS

    
    Test                             Normal level*    Action level*    Symptomatic level*

    Plasma cholinesterase                 100%           50%               variable
    Erythrocyte cholinesterase            100%           70%             usually < 40%

    
    (* Expressed as percentage of pre-exposure activity.)

    Urinary levels of either extractable organic phosphorus may also be
    used to determine the degree of exposure.

    5.3  LABORATORY METHODS

    5.3.1  Detection and assay of compound

    References are given only

    Gas chromatographic methods for analysis of fensulfothion and
    metabolites are the methods of choice for residue analysis of
    various crops, animal tissues and milk. GLC methods utilizing a KGL
    thermionic detector proved to be particularly suitable for
    regulatory purposes. See: Katague & Olson, 1969, Olson, 1970 and
    1971. GLC methods have been developed for the determination of
    individual metabolites (Williams et al., 1971; Bowman & Hill, 1971).
    Gas chromatographic methods for determination of fensulfothion and
    metabolites in soil have been developed (Olson, 1968; Katague,
    1966).

    5.3.2  Other tests in cases of poisoning

    Levels of cholinesterase in blood provide the most useful diagnosis
    of poisoning. See: Michel, N. O. (1949), J. Lab. Clin. Med., 34,
    1564-1568. Ellman, G. L., Courtney, K. D., Andreas, V. jr &
    Featherstone, R. M., (1961) Biochem. Pharmacol., 2, 88-95.

    Urinary levels of diethyl phosphate and phosphorothioate can also be
    used to determine exposure: method of Shafik & Enos (1969) as
    modified by Shafik et al. (1970).

                                    = = =


    See Also:
       Toxicological Abbreviations
       Fensulfothion (ICSC)
       Fensulfothion (WHO Pesticide Residues Series 2)
       Fensulfothion (Pesticide residues in food: 1982 evaluations)
       Fensulfothion (Pesticide residues in food: 1983 evaluations)